S. 289 - American Cures Act
- Sponsor:
- Richard J. Durbin
- Summary:
- A bill to prioritize funding for an expanded and sustained national investment in biomedical research. (by CRS)
- Status:
- The bill has been referred to committee.
American Cures Act
S. 289 — 114th Congress (2015–2016)
- Summary
- A bill to prioritize funding for an expanded and sustained national investment in biomedical research. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to prioritize funding for an expanded and sustained national investment in biomedical research.
- Other Titles
- American Cures Act
- American Cures Act
- Sponsor
- Richard J. Durbin
- Co-Sponsors
- Subjects
- Health
- Appropriations
- Budget process
- Centers for Disease Control and Prevention (CDC)
- Defense spending
- Department of Defense
- Department of Health and Human Services
- Department of Veterans Affairs
- Disability and paralysis
- Executive agency funding and structure
- Medical research
- Military medicine
- National Institutes of Health (NIH)
- Research administration and funding
- Veterans' medical care
- Related Bills
- Major Actions
Introduced 1/28/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 1/28/2015 1/28/2015 Read twice and referred to the Committee on the Budget. 1/28/2015 Introduced in Senate Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
Contributions data source: OpenSecrets.org